June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
PRGF-Endoret® in corneal tissue engineering
Author Affiliations & Notes
  • Ana Cristina Riestra
    Universidad de Oviedo, Oviedo, Spain
    Instituto Oftalmológico Fernández-Vega, Oviedo, Spain
  • Natalia Vázquez
    Universidad de Oviedo, Oviedo, Spain
    Fundación de Investigación Oftalmológica, Oviedo, Spain
  • Manuel Chacón
    Instituto Oftalmológico Fernández-Vega, Oviedo, Spain
    Fundación de Investigación Oftalmológica, Oviedo, Spain
  • Eva García
    CIBERER U714, Oviedo, Spain
    Universidad Carlos III, Madrid, Spain
  • Alvaro Meana
    Fundación de Investigación Oftalmológica, Oviedo, Spain
    CIBERER U714, Oviedo, Spain
  • Gorka Orive
    Biotechnology Institute, Vitoria, Spain
  • Eduardo Anitua
    Biotechnology Institute, Vitoria, Spain
  • Jesus Merayo-Lloves
    Universidad de Oviedo, Oviedo, Spain
    Fundación de Investigación Oftalmológica, Oviedo, Spain
  • Footnotes
    Commercial Relationships Ana Cristina Riestra, None; Natalia Vázquez, None; Manuel Chacón, None; Eva García, None; Alvaro Meana, None; Gorka Orive, Biotechnology Institute (E); Eduardo Anitua, Biotechnological Institute (E); Jesus Merayo-Lloves, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 2261. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Ana Cristina Riestra, Natalia Vázquez, Manuel Chacón, Eva García, Alvaro Meana, Gorka Orive, Eduardo Anitua, Jesus Merayo-Lloves; PRGF-Endoret® in corneal tissue engineering. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):2261.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The objective of the present study is to analyze the potential use of PRGF-Endoret® in every step of corneal tissue engineering, supplementing the culture media and as a scaffold for limbal stem cells.

Methods: PRGF-Endoret® derivatives: Plasma rich in growth factors (PRGF) eye drop was obtained using the Endoret (PRGF) kit in Ophthalmology (BTI Biotechnology Institute, S.L., Vitoria, Spain). Briefly, blood was collected from healthy donors into 9 mL tubes containing sodium citrate as anticoagulant. Blood was centrifuged at 580g for 8 minutes; whole plasma column was drawn off avoiding the buffy coat, activated with CaCl2 and incubated at 37 0C for one hour until membrane coagulation. The released supernatants were collected, filtered, aliquoted and stored at - 800C until use in the following culture media: Basal medium (BM): DMEM/F12 supplemented with 1% antibiotics and 10% PRGF-Endoret® (BMPRGF) or FBS (BMFBS). Classic medium (CM): DMEM/F12 supplemented with 5mg/ml insulin, 8.33ng/ml cholera toxin, 24mg/ml adenine, 1.3ng/ml triiodothyronine, 0.4mg/ml hydrocortisone, 1% antibiotics and 10% PRGF-Endoret® (CMPRGF) or FBS (CMFBS). Proliferation assays: Limbal stem cells were obtained from explants of 2-3mm in diameter of the limbal region and cultured on the media described above. At 7 days, cells were fixed in ice-cold methanol and their proliferation was assessed by quantification of the growth area. Culture on PRGF-Endoret® membrane: Human limbal stem cells were cultured on PRGF-Endoret® membranes. Once confluent, membranes were fixed and analyzed by phase contrast microscopy, scanning electron microscopy and immunocytochemistry for p63 and cytokeratin in order to check their immunological markers.

Results: Growth area in cultures in CMPRGF was significantly better (p<0.05) than cultures in CMFBS, and, even though all cultures in BM were significantly lower (p<0.05) than cultures in CM, BMPRGF shows a significantly better (p<0.01) growth area than cultures in BMFBS, being as effective as CMFBS. In the other hand, limbal stem cells seems to attach and proliferate on a PRGF-Endoret® membrane maintaining their cellular markers with PRGF-Endoret®, instead of FBS, as supplement in the culture media.

Conclusions: PRGF-Endoret® could be used in corneal tissue engineering, both, supplementing the culture media, even in a basal media without any other additives, as well as scaffold for the culture of the limbal stem cells.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×